Ortega-Alonzo SE, Hinojosa-Lezama JM

Idioma: Español
Referencias bibliográficas: 30
Paginas: 203-207
Archivo PDF: 209.91 Kb.

RESUMEN

Se presenta el caso clínico de un paciente de seis años con episodios recurrentes de hematuria macroscópica asociados en su mayoría a infecciones de vías respiratorias superiores. Se descarta afectación secundaria y se maneja con sospecha clínica de nefropatía por IgA primaria, condición con bajo riesgo de progresión a enfermedad renal crónica de forma conservadora, siendo una enfermedad frecuente pero raramente diagnosticada por el médico de primer contacto. En este estudio se informa sobre los avances en la fisiopatología y el diagnóstico de la enfermedad, los aspectos clínicos e histopatológicos del paciente pediátrico con enfermedad renal, el dilema de la toma de biopsia renal en una entidad que se presenta a temprana edad y se padece de por vida, el pronóstico y tratamiento del paciente con hematuria de origen glomerular.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013; 368(25): 2402-2414.

2. Chávez VV, Orizaga CC, Becerra FJG, Fuentes RF, Parra MR, Aragaki Y et al. Epidemiología de la enfermedad glomerular en adultos. Revisión de una base de datos. Gac Med Mex. 2014; 150: 403-408.

3. Hanko JB, Mullan RN, O’Rourke DM, McNamee PT, Maxwell AP, Courtney AE. The changing pattern of adult primary glomerular disease. Nephrol Dial Transplant. 2009; 24(10): 3050-3054.

4. Swaminathan S, Leung N, Lager DJ, Melton LJ, Bergstralh EJ, Rohlinger A et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol. 2006; 1(3): 483-487.

5. Berger J, Hinglais N. Intercapillary deposits of IgA-IgG. J Urol Nephrol. 1968; 74: 694-695.

6. Feehally J, Cameron JS. IgA nephropathy: progress before and since berger. Am J Kidney Dis. 2011; 58(2): 310-319.

7. Novak J, Julian BA, Mestecky J, Renfrow MB. Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol. 2012; 34(3): 365-382.

8. Salvadori M, Rosso G. Update on immunoglobulin A nephropathy, Part I: pathophysiology. World J Nephrol. 2015; 4(4): 455-467.

9. Floege J, Gröne H. IgA-nephropathy: frequent, but rarely diagnosed. Internist (Berl). 2003; 44(9): 1131-1139.

10. Hicks J, Mierau G, Wartchow E, Eldin K. Renal diseases associated with hematuria in children and adolescents: a brief tutorial. Ultrastruct Pathol. 2012; 36(1): 1-18.

11. Choyke PL. Radiologic evaluation of hematuria: guidelines from the American College of Radiology’s appropriateness criteria. Am Fam Physician. 2008; 78(3): 347-352.

12. Moloney F, Murphy K, Twomey M, O’Connor O, Maher M. Haematuria: an imaging guide. Adv Urol. 2014; 2014: 414125.

13. Davis TK, Hmiel P. Pediatric hematuria remains a clinical dilemma. Clin Pediatr. 2015; 54(9): 817-830.

14. Salvadori M, Rosso G. Update on immunoglobulin A nephropathy, Part II: clinical, diagnostic and therapeutic aspects. World J Nephrol. 2016; 5(1): 6-19.

15. Yu HH, Chiang BL. Diagnosis and classification of IgA nephropathy. Autoimmun Rev. 2014; 13(4-5): 556-559.

16. Coppo R, Davin JC. The difficulty in considering modifiable pathology risk factors in children with IgA nephropathy: crescents and timing of renal biopsy. Pediatr Nephrol. 2014; 30(2): 189-192.

17. Moresco RN, Speeckaert MM, Delanghe JR. Diagnosis and monitoring of IgA nephropathy: The role of biomarkers as an alternative to renal biopsy. Autoimmun Rev. 2015; 14(10): 847-853.

18. Brachemi S, Bollée G. Renal biopsy practice: What is the gold standard? World J Nephrol. 2014; 3(4): 287-294.

19. Peters B, Stegmayr B, Andersson Y, Hadimeri H, Mölne J. Increased risk of renal biopsy complications in patients with IgA-nephritis. Clin Exp Nephrol. 2015; 19(6): 1135-1141.

20. Shima Y, Nakanishi K, Hama T, Sato M, Mukaiyama H, Togawa H et al. Biopsy timing and Oxford classification variables in Childhood/Adolescent IgA nephropathy. Pediatr Nephrol. 2015; 30(2): 293-299.

21. Feng CY, Xia YH, Wang WJ, Xia J, Fu HD, Wang X et al. Persistent asymptomatic isolated hematuria in children: Clinical and histopathological features and prognosis. World J Pediatr. 2013; 9(2): 163-168.

22. Wang T, Ye F, Meng H, Zhang L, Jin X. Comparison of clinicopathological features between children and adults with IgA nephropathy. Pediatr Nephrol. 2012; 27(8): 1293-1300.

23. Julian BA, Wittke S, Haubitz M, Zürbig P, Schiffer E, McGuire BM et al. Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases. World J Urol. 2007; 25(5): 467-476.

24. Suzuki Y, Suzuki H, Makita Y, Takahata A, Takahashi K, Muto M et al. Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers. Int J Nephrol Renovasc Dis. 2014; 7: 409-414.

25. Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J et al. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int. 2014; 86(4): 828-836.

26. Tanaka K, Moriyama T, Iwasaki C, Takei T, Nitta K. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria. Clin Exp Nephrol. 2014; 19(5): 815-821.

27. Barakat AJ. Presentation of the child with renal disease and guidelines for referral to the pediatric nephrologist. Int J Pediatr. 2012; 2012(2): 1-5.

28. Smart NA, Dieberg G, Ladhani M, Titus T. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. 2014; 6(6): CD007333.

29. Group KW. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012; 2(2): 1-274.

30. Wang Y, Chen J, Wang Y, Chen Y, Wang L, Lv Y. A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant. 2011; 26: 1923-1931.